Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions
- PMID: 12767466
- DOI: 10.1016/s0166-3542(03)00069-x
Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions
Abstract
Nucleoside reverse transcriptase inhibitors (NRTIs) in combination with other antiretrovirals (HAART) are critical in current AIDS therapy, but mitochondrial side effects have come to light with the increased use of these compounds. Clinical experience, pharmacological, cell and molecular biological evidence links altered mitochondrial (mt-) DNA replication to the toxicity of NRTIs in many tissues, and conversely, mtDNA replication defects and mtDNA depletion in specific target tissues are observed. The shared features of mtDNA depletion and energy depletion became key observations and related the clinical and in vivo experimental findings to inhibition of mtDNA replication by NRTI triphosphates in vitro. Subsequent to those findings, other observations suggested that mitochondrial energy deprivation is concomitant with or the result of mitochondrial oxidative stress in AIDS (from HIV, for example) or from NRTI therapy itself. With increased use of NRTIs, mtDNA mutations may become increasingly important pathophysiologically. One important future goal is to prevent or attenuate the side effects so that improved efficacy is achieved.
Similar articles
-
Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy.Prog Cardiovasc Dis. 2003 Jan-Feb;45(4):305-18. doi: 10.1053/pcad.2003.3b. Prog Cardiovasc Dis. 2003. PMID: 12638094 Review.
-
A brief overview of mechanisms of mitochondrial toxicity from NRTIs.Environ Mol Mutagen. 2007 Apr-May;48(3-4):166-72. doi: 10.1002/em.20223. Environ Mol Mutagen. 2007. PMID: 16758472 Review.
-
Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1493-504. doi: 10.1517/17425255.2010.526602. Epub 2010 Oct 7. Expert Opin Drug Metab Toxicol. 2010. PMID: 20929279 Review.
-
Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):406-413. doi: 10.1016/j.bbadis.2016.11.017. Epub 2016 Nov 11. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 27840304
-
Nucleoside reverse transcriptase inhibitors induced hepatocellular mitochondrial DNA lesions and compensatory enhancement of mitochondrial function and DNA repair.Int J Antimicrob Agents. 2018 Mar;51(3):385-392. doi: 10.1016/j.ijantimicag.2017.08.017. Epub 2017 Aug 24. Int J Antimicrob Agents. 2018. PMID: 28843815
Cited by
-
Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase.Biochemistry. 2003 Dec 23;42(50):14711-9. doi: 10.1021/bi035596s. Biochemistry. 2003. PMID: 14674745 Free PMC article. Review.
-
The New Epidemiology of HIV-Related Kidney Disease.J AIDS Clin Res. 2012;Suppl 4:001. doi: 10.4172/2155-6113.S4-001. J AIDS Clin Res. 2012. PMID: 25309811 Free PMC article.
-
Aging and HIV/AIDS: pathogenetic role of therapeutic side effects.Lab Invest. 2014 Feb;94(2):120-8. doi: 10.1038/labinvest.2013.142. Epub 2013 Dec 16. Lab Invest. 2014. PMID: 24336070 Free PMC article. Review.
-
Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study.Curr Ther Res Clin Exp. 2005 Mar;66(2):117-29. doi: 10.1016/j.curtheres.2005.04.002. Curr Ther Res Clin Exp. 2005. PMID: 24672118 Free PMC article.
-
Neurotoxic effects of AZT on developing and adult neurogenesis.Front Neurosci. 2015 Mar 20;9:93. doi: 10.3389/fnins.2015.00093. eCollection 2015. Front Neurosci. 2015. PMID: 25852464 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical